John Tann

Pesticide-Induced Mosquito Death Outweighs Fitness Advantage Of Survivors

Article
Health & Wellness
Natural Health
+3
Contributed byKrish Tangella MD, MBAMar 01, 2016

A common toxin used to kill yellow fever mosquito larvae -- the most prevalent transmitter of dengue, chikungunya and zika viruses -- is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Scientists and mosquito control officials want to kill mosquitoes during the larval, or juvenile stage, before they grow into adulthood and transmit these dangerous diseases. Dengue and chikungunya viruses are regarded as two of the most important mosquito-borne viral illnesses, said Barry Alto, a UF/IFAS assistant professor in entomology at the UF/IFAS Florida Medical Entomology Laboratory in Vero Beach, Florida.

The few mosquitos that do survive after exposure to the toxin gain a fitness advantage in adulthood, but their numbers are so small that their trait improvements, including enhanced size and ability to reproduce, are unlikely to outweigh the benefit of the rest of the mosquitoes that die from the pesticide Bacillus thuringiensis israelensis (Bti), Alto said.

Zika is an emerging virus, with cases imported to Florida and other parts of the United States, but no zika cases have been locally transmitted by zika virus-infected mosquitoes in the continental U.S., yet, Alto said. Public health officials in the Americas are concerned about a recent outbreak of zika fever in numerous countries and territories in the Americas due to microcephaly -- small crania -- and other congenital issues with newborn babies, likely associated with maternal zika infection during pregnancy.

"Both dengue and chikungunya activity have increased in Florida in recent years, and so these diseases pose a serious public health threat," he said. "Controlling the mosquito populations is currently the most effective approach used to control these diseases."

In the study, published Feb. 12 in the journal PLOS Neglected Tropical Diseases, scientists found changes in some traits of mosquitoes but no significant changes in yellow fever mosquitoes' susceptibility to dengue virus infection after exposure to Bti.

"The pesticide changes the environmental conditions -- including killing many other mosquito competitors -- so the remaining mosquitoes that mature into adults are different in many ways, compared to mosquitoes that were never exposed to the pesticide," said Alto, who conducted the study with Cynthia Lord, an associate professor in entomology at the Vero Beach lab. This study is one of the most comprehensive investigations of the lethal and nonlethal impacts of this pesticide on mosquitoes, Alto said.



The above post is reprinted from materials provided by University of Florida Institute of Food and Agricultural Sciences. The original item was written by Brad Buck. Note: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Alto, B. W., & Lord, C. C. (2016). Transstadial Effects of Bti on Traits of Aedes aegypti and Infection with Dengue Virus. PLOS Negl Trop Dis10(2), e0004370.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!